Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

25.68
-0.3100-1.19%
Volume:797.65K
Turnover:20.44M
Market Cap:4.10B
PE:-62.44
High:25.99
Open:25.63
Low:25.10
Close:25.99
52wk High:26.16
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.61
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:28.71
PE(LYR):-65.48

Loading ...

J.P. Morgan Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)

TIPRANKS
·
May 06

Stock Track | Adaptive Biotechnologies Soars 5.30% in Night Session on Strong Q1 Earnings Beat

Stock Track
·
May 06

Adaptive Biotechnologies Q1 revenue beats estimates on MRD growth

Reuters
·
May 06

Stock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat

Stock Track
·
May 06

Adaptive Biotechnologies Q1 EPS $(0.13) Beats $(0.17) Estimate, Sales $70.874M Beat $60.850M Estimate

Benzinga Earnings
·
May 06

BRIEF-Adaptive Biotechnologies Q1 EPS USD -0.13

Reuters
·
May 06

Adaptive Biotechnologies Q1 Net Income USD -20.015 Million

THOMSON REUTERS
·
May 06

Adaptive Biotechnologies Corp - Sees FY2026 Operating Expenses $350 Mln-$360 Mln

THOMSON REUTERS
·
May 06

Adaptive Biotechnologies Q1 Adjusted Ebitda USD -2.5 Million VS. Ibes Estimate USD -6.55 Million

THOMSON REUTERS
·
May 06

Stock Track | Adaptive Biotechnologies Plummets 5.03% Intraday Ahead of Q1 Earnings Report

Stock Track
·
May 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Assessing Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness

Simply Wall St.
·
May 03

Adaptive Biotech President, COO Julie Rubinstein sells 19,037 shares for $270,197.51

Reuters
·
Apr 30

Earning Preview: Adaptive Biotechnologies Corp Q1 revenue is expected to increase by 42.58%, and institutional views are cautiously bullish

Earnings Agent
·
Apr 29

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of shares worth $802,123.4

Reuters
·
Apr 25

Adaptive Biotechnologies President, COO Julie Rubinstein sells $994,273 common shares

Reuters
·
Apr 22

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of $832,436 common shares

Reuters
·
Apr 17

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

Adaptive Biotechnologies Corp : TD Cowen Cuts Target Price to $19 From $21

THOMSON REUTERS
·
Apr 14

Adaptive Biotechnologies President and COO Julie Rubinstein sells USD 526,477 shares

Reuters
·
Apr 14